We are live on
!
Find out more
VCM
Versant Capital Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
34.21%
This Fund
S&P 500
This Quarter
Est. Return
+13.52%
1 Year Est. Return
+34.21%
3 Year Est. Return
+82.39%
5 Year Est. Return
+89.4%
10 Year Est. Return
+245.39%
AUM
$1.12B
AUM Growth
+$101M
(+10%)
Cap. Flow
+$19.1M
Cap. Flow
% of AUM
1.71%
Top 10 Holdings %
Top 10 Hldgs %
31.56%
Holding
2,873
New
96
Increased
1,181
Reduced
859
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXUV
Dimensional US Vector Equity ETF
DXUV
|
+$8.37M |
| 2 |
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
|
+$7.66M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$6.75M |
| 4 |
DXIV
Dimensional International Vector Equity ETF
DXIV
|
+$4.35M |
| 5 |
Dimensional Emerging Markets Value ETF
DFEV
|
+$2.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$2.11M |
| 2 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$2.02M |
| 3 |
Vanguard Total Stock Market ETF
VTI
|
+$1.88M |
| 4 |
CoreCivic
CXW
|
+$1.84M |
| 5 |
Apple
AAPL
|
+$1.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.06% |
| 2 | Financials | 7.05% |
| 3 | Industrials | 6.04% |
| 4 | Consumer Discretionary | 4.74% |
| 5 | Healthcare | 4.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TEM
2051
Tempus AI
TEM
$7.69B
| $15.6K | ﹤0.01% |
270
+189
| +233% | +$9.48K |
|
2052
Butterfly Network
BFLY
$1.72B
| $15.6K | ﹤0.01% |
1,851
+1,713
| +1,241% | +$8.87K |
|
|
ONT
2053
Onterris Inc
ONT
$710M
| $15.6K | ﹤0.01% |
770
+394
| +105% | +$7.35K |
|
|
RWT
2054
Redwood Trust
RWT
$616M
| $15.5K | ﹤0.01% |
3,271
-10,137
| -76% | -$55.1K |
|
|
ONIT
2055
Onity Group
ONIT
$333M
| $15.5K | ﹤0.01% |
390
+262
| +205% | +$10.3K |
|
2056
Seneca Foods Class A
SENEA
$1.13B
| $15.5K | ﹤0.01% |
89
| – | – |
|
|
CCC
2057
CCC Intelligent Solutions
CCC
$3.42B
| $15.5K | ﹤0.01% |
2,995
+1,150
| +62% | +$5.69K |
|
2058
Shutterstock
SSTK
$205M
| $15.4K | ﹤0.01% |
1,107
-2,237
| -67% | -$35.2K |
|
2059
PGIM Ultra Short Bond ETF
PULS
$17.7B
| $15.4K | ﹤0.01% |
311
| – | – |
|
|
2060
iShares 3-7 Year Treasury Bond ETF
IEI
$18.1B
| $15.4K | ﹤0.01% |
131
-17,945
| -99% | -$2.11M |
|
2061
Burke & Herbert Financial Services Corp
BHRB
$1.42B
| $15.4K | ﹤0.01% |
214
+164
| +328% | +$10.6K |
|
2062
Americold
COLD
$4.09B
| $15.4K | ﹤0.01% |
978
+509
| +109% | +$6.99K |
|
2063
Veracyte
VCYT
$4.52B
| $15.3K | ﹤0.01% |
261
-33
| -11% | -$1.38K |
|
2064
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.59B
| $15.3K | ﹤0.01% |
149
| – | – |
|
|
ALMS
2065
Alumis Inc
ALMS
$3.57B
| $15.3K | ﹤0.01% |
543
| – | – |
|
|
CRCL
2066
Circle Internet Group
CRCL
$15.5B
| $15.2K | ﹤0.01% |
243
+206
| +557% | +$20K |
|
2067
Flowserve
FLS
$9.25B
| $15.2K | ﹤0.01% |
205
-108
| -35% | -$8.21K |
|
2068
RUM Group Inc
RUM
$1.57B
| $15.2K | ﹤0.01% |
2,394
+339
| +16% | +$2.41K |
|
2069
National Health Investors
NHI
$3.9B
| $15.2K | ﹤0.01% |
199
+119
| +149% | +$9.11K |
|
2070
LivaNova
LIVN
$4.3B
| $15.1K | ﹤0.01% |
184
+69
| +60% | +$4.88K |
|
2071
Whirlpool
WHR
$2.42B
| $15K | ﹤0.01% |
381
+378
| +12,600% | +$17.7K |
|
2072
The RMR Group
RMR
$342M
| $15K | ﹤0.01% |
731
| – | – |
|
2073
Olema Pharmaceuticals
OLMA
$1.02B
| $15K | ﹤0.01% |
1,198
-181
| -13% | -$2.42K |
|
2074
Kimco Realty
KIM
$17.6B
| $15K | ﹤0.01% |
591
+459
| +348% | +$11K |
|
2075
Timberland Bancorp
TSBK
$343M
| $15K | ﹤0.01% |
334
| – | – |
|
Similar funds
FLAM
AIM
MTCM
CNC
NOSC
RIM
ACG
C
Versant Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Versant Capital Management held 2,873 positions worth $1.12B, up 10% from $1.01B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Versant Capital Management's Q2 2026 filing shows 96 new, 1,181 increased, 859 reduced and 128 closed positions. Its largest new stake was AstraZeneca: 7,263 shares worth $1.36M. The largest sale was iShares 3-7 Year Treasury Bond ETF, an estimated $2.11M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Industrials.
- Versant Capital Management's largest Q2 2026 buy was AstraZeneca: 7,263 shares worth $1.36M.
- Versant Capital Management added most to Dimensional US Vector Equity ETF in Q2 2026, an estimated $8.37M increase.
- Versant Capital Management's biggest Q2 2026 reduction was iShares 3-7 Year Treasury Bond ETF, cutting an estimated $2.11M.
- Versant Capital Management fully exited iShares 5-10 Year Investment Grade Corporate Bond ETF in Q2 2026, selling an estimated $2.02M.
- Versant Capital Management's ten largest holdings make up 32% of its $1.12B portfolio in Q2 2026.
- Versant Capital Management opened 96 new positions and closed 128 in Q2 2026.
- Versant Capital Management's portfolio value rose 10% quarter-over-quarter to $1.12B.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.